![]()
|
|
||||||||
J. Biol. Chem., Vol. 282, Issue 13, 9526-9535, March 30, 2007
| ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
1
2
3
4
From the
Department of Pharmacology, University of Cambridge, Tennis Court Road, Cambridge CB2 1PD, United Kingdom and the
Department of Pharmacology, Uniformed Services University of the Health Sciences, Bethesda, Maryland 20814
Inositol 1,4,5-trisphosphate (Ins(1,4,5)P3) 3-kinases (IP3Ks) are a group of calmodulin-regulated inositol polyphosphate kinases (IPKs) that convert the second messenger Ins(1,4,5)P3 into inositol 1,3,4,5-tetrakisphosphate. However, what they contribute to the complexities of Ca2+ signaling, and how, is still not fully understood. In this study, we have used a simple Ca2+ imaging assay to compare the abilities of various Ins (1,4,5)P3-metabolizing enzymes to regulate a maximal histamine-stimulated Ca2+ signal in HeLa cells. Using transient transfection, we overexpressed green fluorescent protein-tagged versions of all three mammalian IP3K isoforms, including mutants with disrupted cellular localization or calmodulin regulation, and then imaged the Ca2+ release stimulated by 100 µM histamine. Both localization to the F-actin cytoskeleton and calmodulin regulation enhance the efficiency of mammalian IP3Ks to dampen the Ins (1,4,5)P3-mediated Ca2+ signals. We also compared the effects of the these IP3Ks with other enzymes that metabolize Ins(1,4,5)P3, including the Type I Ins(1,4,5)P3 5-phosphatase, in both membrane-targeted and soluble forms, the human inositol polyphosphate multikinase, and the two isoforms of IP3K found in Drosophila. All reduce the Ca2+ signal but to varying degrees. We demonstrate that the activity of only one of two IP3K isoforms from Drosophila is positively regulated by calmodulin and that neither isoform associates with the cytoskeleton. Together the data suggest that IP3Ks evolved to regulate kinetic and spatial aspects of Ins (1,4,5)P3 signals in increasingly complex ways in vertebrates, consistent with their probable roles in the regulation of higher brain and immune function.
Received for publication, November 2, 2006 , and in revised form, January 11, 2007.
* The costs of publication of this article were defrayed in part by the payment of page charges. This article must therefore be hereby marked "advertisement" in accordance with 18 U.S.C. Section 1734 solely to indicate this fact.
1 Supported by a Studentship from Merck Sharp & Dohme.
2 Supported by the Croucher Foundation.
4 Supported by the Case Fellowship from the Royal Society and by Uniformed Services University of the Health Sciences Grant RO75LN.
3 Supported by the Royal Society and the Wellcome Trust. To whom correspondence should be addressed: Dept. of Pharmacology, University of Cambridge, Tennis Ct. Rd., Cambridge CB2 1PD, United Kingdom. Tel.: 44-1223-339683; Fax: 44-1223-334040; E-mail: rfi20{at}cam.ac.uk.
![]()
CiteULike
Complore
Connotea
Del.icio.us
Digg
Reddit
Technorati What's this?
| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |
| All ASBMB Journals | Molecular and Cellular Proteomics |
| Journal of Lipid Research | ASBMB Today |